-
EP2041177
European procedure
Extract from the Register of European Patents
EP About this file: EP2041177
| EP2041177 - HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.10.2012 Database last updated on 01.04.2026 | Most recent event Tooltip | 03.05.2013 | Lapse of the patent in a contracting state | published on 05.06.2013 [2013/23] | Applicant(s) | For all designated states REGENERON PHARMACEUTICALS, INC. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2009/14] | Inventor(s) | 01 /
STEVENS, Sean 3001 Lexington Avenue Mohegan Lake, NY 10547 / US | 02 /
HUANG, Tammy T. 10 Green Hill Road Golden Bridge, NY 10526 / US | 03 /
MARTIN, Joel H. 244 Church Road Putnam Valley, NY 10579 / US | 04 /
FAIRHURST, Jeanette L. 23 Parkview Court White Plains, NY 10603 / US | 05 /
RAFIQUE, Ashique 99 Franklin Avenue Yonkers, NY 10705 / US | 06 /
SMITH, Eric 230 East 30th, Street, Apt.5E New York, NY 10016 / US | 07 /
POBURSKY, Kevin J. 60 Anderson Street Beacon, NY 12508 / US | 08 /
PAPADOPOULOS, Nicholas J. 59 Heritage Lane Lagrangeville, NY 12540 / US | 09 /
FANDL, James P. 40 Amanda's Way Lagrangeville, NY 12540 / US | 10 /
CHEN, Gang 2478 Mill Pond Road Yorktown Heights, NY 10598 / US | 11 /
KAROW, Margaret 12655 Ridge Drive Camarillo, CA 93012 / US | [2009/14] | Representative(s) | Bentham, Andrew J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
| Former [2011/50] | Bentham, Andrew J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
| Former [2009/14] | Bentham, Andrew J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 07777380.2 | 01.06.2007 | [2009/14] | WO2007US13062 | Priority number, date | US20060810664P | 02.06.2006 Original published format: US 810664 P | US20060843232P | 08.09.2006 Original published format: US 843232 P | [2009/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007143168 | Date: | 13.12.2007 | Language: | EN | [2007/50] | Type: | A2 Application without search report | No.: | EP2041177 | Date: | 01.04.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.12.2007 takes the place of the publication of the European patent application. | [2009/14] | Type: | B1 Patent specification | No.: | EP2041177 | Date: | 14.12.2011 | Language: | EN | [2011/50] | Search report(s) | International search report - published on: | EP | 24.04.2008 | Classification | IPC: | C07K16/28, C12N15/13, A61K39/00 | [2009/14] | CPC: |
C07K16/2866 (EP,KR,NO,US);
A61K40/00 (KR);
A61P1/00 (EP);
A61P1/04 (EP,KR);
A61P19/02 (EP,KR);
A61P29/00 (EP,KR);
A61P37/00 (EP);
A61P37/02 (EP,KR);
C07K16/26 (KR);
C12N15/11 (KR);
A61K2039/505 (EP,KR,NO,US);
C07K2317/14 (KR,NO,US);
C07K2317/21 (EP,KR,NO,US);
C07K2317/56 (NO,US);
C07K2317/565 (KR,NO,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/14] | Extension states | AL | 24.11.2008 | BA | 24.11.2008 | HR | 24.11.2008 | MK | 24.11.2008 | RS | 24.11.2008 | Title | German: | HOCHAFFINE ANTIKÖRPER GEGEN DEN HUMANEN IL-6-REZEPTOR | [2009/14] | English: | HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR | [2009/14] | French: | ANTICORPS DIRIGÉS CONTRE LE RÉCEPTEUR DE L'IL-6 HUMAINE, À AFFINITÉ ÉLEVÉE POUR LEDIT RÉCEPTEUR | [2009/14] | Entry into regional phase | 24.11.2008 | National basic fee paid | 24.11.2008 | Designation fee(s) paid | 24.11.2008 | Examination fee paid | Examination procedure | 24.11.2008 | Examination requested [2009/14] | 30.01.2009 | Amendment by applicant (claims and/or description) | 21.01.2011 | Despatch of a communication from the examining division (Time limit: M04) | 20.04.2011 | Reply to a communication from the examining division | 10.06.2011 | Communication of intention to grant the patent | 27.09.2011 | Fee for grant paid | 27.09.2011 | Fee for publishing/printing paid | Divisional application(s) | EP11171039.8 / EP2374818 | EP12191147.3 Application deemed to be withdrawn : 04.12.2012 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.01.2011 | Opposition(s) | 17.09.2012 | No opposition filed within time limit [2012/47] | Fees paid | Renewal fee | 26.06.2009 | Renewal fee patent year 03 | 25.06.2010 | Renewal fee patent year 04 | 27.06.2011 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SK | 01.06.2012 | [2013/23] | Cited in | International search | [Y] MIHARA ET AL: "Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family", INTERNATIONAL IMMUNOPHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 5, no. 12, November 2005 (2005-11-01), pages 1731 - 1740, XP005020014, ISSN: 1567-5769 [Y] 1-19 * the whole document * | [PY] PAUL-PLETZER KALANETHEE: "Tocilizumab: Blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders", DRUGS OF TODAY, vol. 42, no. 9, September 2006 (2006-09-01), pages 559 - 576, XP002462414, ISSN: 1699-3993 [PY] 1-19 * the whole document * DOI: http://dx.doi.org/10.1358/dot.2006.42.9.1025692 | by applicant | REDDY ET AL., J. IMMUNOL., vol. 164, 2000, pages 1925 - 1933 | HOLLIGER ET AL., PROC. NATL. ACAD SCI. USA, vol. 90, 1993, pages 6444 - 6448 |